-

Kirby McInerney LLP Announces an Investigation of Shareholder Claims on Behalf of Lockheed Martin Corporation (LMT) Investors

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against Lockheed Martin Corporation (“Lockheed Martin” or the “Company”) (NYSE: LMT). The investigation concerns whether Lockheed Martin has violated the federal securities laws and/or engaged in other unlawful business practices.

Lockheed Martin is an American aerospace, arms, defense, information security, and technology corporation with worldwide interests.

On March 16, 2022, Bloomberg reported that the U.S. Department of Defense will request 61 Lockheed F-35 fighter jets in its next budget, 33 fewer than previously planned. Bloomberg reported that the proposed reduction follows the “flawed execution of a crucial upgrade of [the F-35’s] software and hardware capabilities that’s estimated to cost $14 billion.” On this news, Lockheed Martin’s shares declined by $27.33 per share, from $448.67 per share to close at $421.34 per share on March 16, 2022.

If you purchased or otherwise acquired Lockheed Martin securities, have information, or would like to learn more about this investigation, please contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or by filling out this contact form, to discuss your rights or interests with respect to these matters without any cost to you.

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website: http://www.kmllp.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Kirby McInerney LLP
Thomas W. Elrod, Esq.
212-371-6600
https://www.kmllp.com
investigations@kmllp.com

Kirby McInerney LLP

NYSE:LMT

Release Versions
$Cashtags

Contacts

Kirby McInerney LLP
Thomas W. Elrod, Esq.
212-371-6600
https://www.kmllp.com
investigations@kmllp.com

More News From Kirby McInerney LLP

ELV INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Elevance Health, Inc.

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP continues its investigation on behalf of Elevance Health, Inc. (“Elevance” or the “Company”) (NYSE:ELV) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws and other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On March 2, 2026, Elevance disclosed in a filing with the U.S. Securities and Exchange Commission that it “was not...

ALIT INVESTOR REMINDER: Alight, Inc. Investors Have Until May 15, 2026 To Seek Lead Plaintiff Role

NEW YORK--(BUSINESS WIRE)--If you have suffered a loss on your Alight, Inc. (“Alight” or the “Company”) (NYSE:ALIT) investment, contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost. Investors have until May 15, 2026 to ask the Court to appoint them as lead plaintiff. Courts do not consider applications filed after this deadline. The lead...

LAKE DEADLINE NOTICE: Lakeland Industries, Inc. Investors Encouraged to Contact Kirby McInerney LLP By April 24, 2026

NEW YORK--(BUSINESS WIRE)--If you suffered a loss on your investment in Lakeland Industries, Inc. (“Lakeland” or the “Company”) (NASDAQ:LAKE), contact Lauren Molinaro by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost. Investors have until April 24, 2026 to ask the Court to appoint them as lead plaintiff. Courts do not consider applications filed after this deadline. The lead plaint...
Back to Newsroom